Are we appropriately screening and treating preoperative anaemia in major elective bowel surgery? by Poon, Edgar et al.
Background
• Anaemia is common in bowel surgery patients due to 
underlying comorbidities.1
• Untreated preoperative anaemia is associated with poor 
perioperative outcomes & increased need for red blood 
cell transfusion.2
• Patient blood management (PBM) is an approach to 
address this issue & improve surgical outcomes, 
particularly for those at risk of significant blood loss.2
Aim
• To evaluate the appropriateness of preoperative anaemia
assessment & its management in major elective bowel 
surgery patients at our hospital; & determine the extent to 
which hospital practice aligned with the National Blood 
Authority PBM Guideline.3
Methods
• Retrospective audit of public & private patients ≥18 years, 
admitted for major, elective bowel surgery at Mater 
Health Brisbane, Jan 2016 to Dec 2018
• DRG codes G01/02 A/B/C used as primary selection 
criteria & patient profiles assessed by a multidisciplinary 
team to ensure selection criteria were met
• Patient data collected from the electronic medical 
records
• Haemoglobin (Hb) used as a primary denominator in 
anaemia screening; Hb levels < 130g/L for men and < 
120g/L for women, were considered ‘anaemic’.
Results
In total, 559 patients were eligible for inclusion. Of these, 
82.8% (n=462) were screened for anaemia preoperatively: 
FBC in 82.1% (n=459) but only 9.1% (n=51) had a ferritin level 
assessed (Table 1).
Table 2 outlines timing of anaemia assessment prior to surgery 
for the 462 screened patients.
Of these:
• 67.1% were assessed ≤ 6 days before surgery. This is 
insufficient time for anaemia correction.
• 36.2% (n=167) patients were found to be anaemic. 
However, only 25.2% (n=42) received treatment (oral or IV 
iron or transfusion) preoperatively. Of those who were non-
anaemic, 2.4% (n=7) received preoperative iron, with 1.4% 
(n=4) receiving IV iron (0.7% of all patients).
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Results (cont’d)
In this cohort, anaemic patients tended to have a longer 
hospital length of stay (mean LOS = 9.9 days) than those who 
were not anaemic (mean LOS = 7.9 days, log-rank: p<0.0001) 
(Figure 1).
Anaemic patients had a higher chance of receiving a 
transfusion than non-anaemic patients (OR: 3.19, p<0.05). They 
also received a higher mean unit(s) of transfusion; however, 
the result was not statistically significant. (2.4 units vs. 1.4 units, 
unpaired t-test: p=0.36).
Conclusions
A gap exists between the PBM guidelines & current practice at 
our hospital.
• Only 4.8% of all patients were appropriately assessed for 
anaemia, receiving at least a full blood count & ferritin test, 
with sufficient time for any anaemia to be identified & 
corrected (1 week up to 6 weeks prior to surgery).
• There is a small chance for some patients to be given IV iron 
when not clinically appropriate, risking iatrogenic injury, e.g. 
life-threatening hypophosphataemia4 or permanent skin 
discolouration5. Thus, the use of parenteral iron in the non-
anaemic population should be discouraged.
Our results are consistent with those from previous studies.
Clinicians should be made aware of this practice gap and 
upskilled to improve patient safety and surgical outcomes.
Next step
Working party established to create a process for patients to     
be reliably screened and treated for anaemia preoperatively.
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Tests Number 
screened
Proportion 
screened (%)
Full blood count 459 82.1%
Ferritin 51 9.1%
Folate & B12 16 3.6%
Renal function 439 78.5%
No testing 97 17.4%
Table 1 – Number of preoperative screening tests 
performed (n=559)
Table 2 – Timing of preoperative anaemia
assessment  for patients assessed (n=462)
Time of anaemia 
preoperative screen
Number 
screened
Proportion 
screened (%)
0 to 1 day 186 40.3%
2 to 6 days 124 26.8%
1 week and up to 6 
weeks
134 29.0%
6 weeks and greater 18 3.9%
Figure 1 – Impact of anaemia status on hospital 
length of stay 
